Anti-CRISPR-mediated control of gene editing and synthetic circuits in eukaryotic cells

Nat Commun. 2019 Jan 14;10(1):194. doi: 10.1038/s41467-018-08158-x.

Abstract

Repurposed CRISPR-Cas molecules provide a useful tool set for broad applications of genomic editing and regulation of gene expression in prokaryotes and eukaryotes. Recent discovery of phage-derived proteins, anti-CRISPRs, which serve to abrogate natural CRISPR anti-phage activity, potentially expands the ability to build synthetic CRISPR-mediated circuits. Here, we characterize a panel of anti-CRISPR molecules for expanded applications to counteract CRISPR-mediated gene activation and repression of reporter and endogenous genes in various cell types. We demonstrate that cells pre-engineered with anti-CRISPR molecules become resistant to gene editing, thus providing a means to generate "write-protected" cells that prevent future gene editing. We further show that anti-CRISPRs can be used to control CRISPR-based gene regulation circuits, including implementation of a pulse generator circuit in mammalian cells. Our work suggests that anti-CRISPR proteins should serve as widely applicable tools for synthetic systems regulating the behavior of eukaryotic cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Video-Audio Media

MeSH terms

  • Bacteriophages / genetics*
  • CRISPR-Cas Systems / genetics*
  • Cell Culture Techniques
  • Clustered Regularly Interspaced Short Palindromic Repeats / genetics
  • Eukaryotic Cells
  • Gene Editing / methods*
  • Gene Regulatory Networks / genetics*
  • Genetic Vectors / genetics
  • HEK293 Cells
  • Humans
  • Induced Pluripotent Stem Cells
  • Intravital Microscopy / methods
  • Lentivirus / genetics
  • Microscopy, Fluorescence / methods
  • Time-Lapse Imaging / methods
  • Transduction, Genetic / methods
  • Transfection / methods